Aksharra Balachandran

Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review.

Frontiers in Pain Research 2022 Aksharra Balachandran, Vanessa K Tassone, Fathima Adamsahib et al.

Pain and depression frequently co-occur. Due to its antidepressant and analgesic properties, ketamine has been used for the management of treatment-resistant depression and pain. This systematic review examined the literature on the efficacy of sub-anesthetic doses of ketamine in individuals experiencing comorbid depression and chronic pain (CDCP), as well as comorbid depression and acute pain...